TIMOTHY LA VOY: Open Payments
NPI 1285625129 · PARIS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 16 payments from 11 companies in 2025. Trend: 2023 $21 · 2024 $0 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $32 |
| Novo Nordisk Inc | 2 | $30 |
| PFIZER INC. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: MOUNJARO, VOQUEZNA, REXULTI, NURTEC ODT, Kerendia, VRAYLAR, FARXIGA, TRELEGY ELLIPTA.
Industry payments across TX — which companies pay providers there.
